Skip to main content
Top
Published in: Diabetologia 10/2020

01-10-2020 | Insulins | Review

Organisation of the human pancreas in health and in diabetes

Authors: Mark A. Atkinson, Martha Campbell-Thompson, Irina Kusmartseva, Klaus H. Kaestner

Published in: Diabetologia | Issue 10/2020

Login to get access

Abstract

For much of the last century, our knowledge regarding the pancreas in type 1 and type 2 diabetes was largely derived from autopsy studies of individuals with these disorders or investigations utilising rodent models of either disease. While many important insights emanated from these efforts, the mode for investigation has increasingly seen change due to the availability of transplant-quality organ-donor tissues, improvements in pancreatic imaging, advances in metabolic assessments of living patients, genetic analyses, technological advances for laboratory investigation and more. As a result, many long-standing notions regarding the role for and the changes that occur in the pancreas in individuals with these disorders have come under question, while, at the same time, new issues (e.g., beta cell persistence, disease heterogeneity, exocrine contributions) have arisen. In this article, we will consider the vital role of the pancreas in human health and physiology, including discussion of its anatomical features and dual (exocrine and endocrine) functions. Specifically, we convey changes that occur in the pancreas of those with either type 1 or type 2 diabetes, with careful attention to the facets that may contribute to the pathogenesis of either disorder. Finally, we discuss the emerging unknowns with the belief that understanding the role of the pancreas in type 1 and type 2 diabetes will lead to improvements in disease diagnosis, understanding of disease heterogeneity and optimisation of treatments at a personalised level.
Appendix
Available only for authorised users
Literature
1.
go back to reference Longnecker DS, Gorelick F, Thompson ED (2018) Anatomy, histology, and fine structure of the pancreas. In: Beger HG, Warshaw AL, Hruban RH et al (eds) The pancreas: an integrated textbook of basic science, medicine, and surgery, 3rd edn. John Wiley & Sons Ltd, Hoboken, NJ, pp 10–23CrossRef Longnecker DS, Gorelick F, Thompson ED (2018) Anatomy, histology, and fine structure of the pancreas. In: Beger HG, Warshaw AL, Hruban RH et al (eds) The pancreas: an integrated textbook of basic science, medicine, and surgery, 3rd edn. John Wiley & Sons Ltd, Hoboken, NJ, pp 10–23CrossRef
31.
go back to reference Henderson JR, Daniel PM, Fraser PA (1981) The pancreas as a single organ: the influence of the endocrine upon the exocrine part of the gland. Gut 22(2):158–167CrossRef Henderson JR, Daniel PM, Fraser PA (1981) The pancreas as a single organ: the influence of the endocrine upon the exocrine part of the gland. Gut 22(2):158–167CrossRef
37.
go back to reference Ma J, Song Z, Yan F (2014) Detection of hepatic and pancreatic fat infiltration in type II diabetes mellitus patients with IDEAL-Quant using 3.0T MR: comparison with single-voxel proton spectroscopy. Chin Med J 127(20):3548–3552PubMed Ma J, Song Z, Yan F (2014) Detection of hepatic and pancreatic fat infiltration in type II diabetes mellitus patients with IDEAL-Quant using 3.0T MR: comparison with single-voxel proton spectroscopy. Chin Med J 127(20):3548–3552PubMed
Metadata
Title
Organisation of the human pancreas in health and in diabetes
Authors
Mark A. Atkinson
Martha Campbell-Thompson
Irina Kusmartseva
Klaus H. Kaestner
Publication date
01-10-2020
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 10/2020
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-020-05203-7

Other articles of this Issue 10/2020

Diabetologia 10/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.